| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 04/27/1993 | US5206235 Animal growth regulators; stimulants |
| 04/27/1993 | US5206234 Benzolactam analogs as antagonists of cck |
| 04/27/1993 | US5206027 Amphipathic compound and liposome comprising the same |
| 04/27/1993 | CA1317068C Peptides influencing diuresis and natriuresis, a process for their preparation, agents containing them, and their use |
| 04/27/1993 | CA1317067C2 Process for their resolution of racemates of optically active bicyclic imino-o-carboxylic esters, and the use of the compounds thus obtainable for the synthesis of carboxyalkyl-dipeptides |
| 04/27/1993 | CA1317066C2 Ligand for forming radiolabeled technetium chelates for use in renal function determinations |
| 04/21/1993 | EP0537199A1 Compositions for treating hiv-type 1 infection |
| 04/20/1993 | US5204462 4h-3,1-benzoxazin-4-one derivative |
| 04/20/1993 | CA1316630C Phosphinylcycloalkylcarbonyl and phosphinylcycloalkenylcarbonyl dipeptides |
| 04/14/1993 | EP0536671A2 Carboxylic acid ester protecting groups, process to prepare them, their coupling to functional groups and their use |
| 04/14/1993 | EP0536324A1 Method for forming an amino acid thiohydantoin using an n-substituted ketenimine activator |
| 04/13/1993 | US5202451 Anchimeric radiometal chelating compounds |
| 04/13/1993 | US5202416 Protease absorbent for isolating and purifying proteases, a process for the preparation therefor, and the method for purifying a protease |
| 04/13/1993 | US5202312 Antiarthritic agents, antiallergens, antidiabetic agents |
| 04/13/1993 | US5202241 Spectrum analysis of physiochemical and biological properties; useful in treatment of infection diseases involving microorganism susceptible to them; culture product |
| 04/13/1993 | US5202235 Enzymatic method for the synthesis and separation of peptides |
| 04/13/1993 | CA1316296C Technetium chelates to be used for determining the renal function |
| 04/08/1993 | CA2079921A1 Carboxylate protective groups, a process for their preparation, their coupling to a functional group, and their use |
| 04/07/1993 | EP0535804A1 Peptide compounds |
| 04/07/1993 | EP0535731A2 Inhibitors of farnesyl protein transferase |
| 04/07/1993 | EP0535730A2 Inhibitors of farnesyl protein transferase |
| 04/07/1993 | EP0535155A1 Libraries of modified peptides with protease resistance |
| 04/07/1993 | EP0535151A1 Peptide library and screening systems |
| 04/07/1993 | EP0311640B1 Higher alkyl pyrrolidone extractants for water soluble phenolic or carboxylic antibiotics |
| 04/06/1993 | US5200507 Using hydrogen fluoride |
| 04/06/1993 | US5200506 Process for preparing new thymopentin retro-inverso analogs and fragments thereof and the intermediates obtained therein |
| 04/06/1993 | US5200426 Preventing the growth or differentiation of common acute lymphoblastic leukemia antigen and human leukemia cells |
| 04/06/1993 | US5200406 Nootropic agents; learning enhancement |
| 04/06/1993 | US5200394 Derivatives of type a and b synergimycins |
| 04/01/1993 | WO1993006127A1 Novel amino acid prodrug renin inhibitors |
| 04/01/1993 | WO1993006121A1 Method of synthesizing diverse collections of oligomers |
| 04/01/1993 | WO1992022583A3 Tri- and tetra-valent monospecific antigen-binding proteins |
| 04/01/1993 | CA2118806A1 Method of synthesizing diverse collections of oligomers |
| 03/31/1993 | EP0534492A2 Carboxyalkyl substituted inhibitors of enkephalinase and ACE |
| 03/31/1993 | EP0534396A2 2-Substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
| 03/31/1993 | EP0534363A2 Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 03/31/1993 | EP0533838A1 Nucleic acid ligands |
| 03/31/1993 | CA2079254A1 Inhibitors of farnesyl protein transferase |
| 03/31/1993 | CA2079253A1 Inhibitors of farnesyl protein transferase |
| 03/30/1993 | US5198426 Renin inhibitors containing c-terminal dihydroxy amides |
| 03/30/1993 | CA1315479C Platelet-aggregation inhibitor peptide derivatives |
| 03/30/1993 | CA1315478C Tripeptide with immunostimulating activity |
| 03/30/1993 | CA1315477C 2-amino acetamide derivatives |
| 03/30/1993 | CA1315475C Process for producing -l-aspartyl-l-phenylalanine methyl ester having an improved solubility |
| 03/30/1993 | CA1315474C Pristinamycin ii b derivatives, their preparation, and pharmaceutical compositions containing them |
| 03/30/1993 | CA1315473C 4-piperidinecarboxamide derivatives |
| 03/30/1993 | CA1315472C Thymopentin retro-inverso analogs and fragments thereof, a process of preparation of the new compounds and the intermediates obtained therein |
| 03/30/1993 | CA1315471C Pyridine-2,4- and 2,5-dicarboxylic acid derivatives, a process for their preparation, the use thereof, and medicaments based on these compounds |
| 03/24/1993 | EP0533350A1 DNA encoding precursor interleukin 1B converting enzyme |
| 03/24/1993 | EP0533342A1 Anti-HIV (AIDS) agents |
| 03/24/1993 | EP0533226A2 Novel chromophore containing compounds |
| 03/24/1993 | EP0533222A1 Method for crystallizing alpha-L-aspartyl-L-phenylalanine methyl ester |
| 03/24/1993 | EP0532915A2 Phosphoinositolglycan-peptide with insulin like activity |
| 03/24/1993 | EP0532693A1 1,4-diamino-2,3-dihydroxybutanes |
| 03/23/1993 | US5196540 Sweetening agent derived from l-aspartic or l-glutamic acid |
| 03/23/1993 | US5196438 Amino acid derivatives |
| 03/23/1993 | CA1315042C2 Methods and compositions for preparation of the tetrapeptide, h-x-omega-u-z-y-tyr-r' |
| 03/23/1993 | CA1315041C2 Methods and compositions for preparation of the tetrapeptide, alpha-t-x-omega-u-z-y-tyr-r' |
| 03/23/1993 | CA1315040C2 Methods and compositions for preparation of the pentapeptide, alpha-t-omega-t' -arg-x-omega-u-z-y-tyr-r' |
| 03/23/1993 | CA1314878C Pristinamycin process |
| 03/18/1993 | WO1993005071A1 INTERLEUKIN 1β PROTEASE AND INTERLEUKIN 1β PROTEASE INHIBITORS |
| 03/18/1993 | WO1993005069A1 New isosteric peptides |
| 03/18/1993 | WO1993005026A1 Peptide isoters containing a heterocycle as h.i.v. inhibitors |
| 03/18/1993 | WO1993005011A1 Novel immunosuppressants |
| 03/18/1993 | CA2116527A1 New isosteric peptides |
| 03/17/1993 | EP0532466A2 Derivatives of 5-amino-4-hydroxy-hexanoic acid and their therapeutical use |
| 03/17/1993 | EP0531461A1 Biologically active peptides containing d-2-alkyltryptophan. |
| 03/17/1993 | EP0276317B1 Gamma-l-glutamyl-l-cysteine ethyl ester and drug containing it as effective ingredient |
| 03/16/1993 | US5194608 Hypotensive agents; inhibits renin-angiotensin system |
| 03/16/1993 | US5194605 Cyclic renin inhibitors containing 2-substituted (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3S,4S)-5-cyclohexyl-3,4-di-hydroxy pentanoic acid or 2-substituted (4S,5S)-5-amino-6-cyclohexyl-4-hydroxyhexanoic acid or its analogs |
| 03/16/1993 | US5194588 Aminoalcohol intermediates for peptide derivatives |
| 03/16/1993 | CA1314655C Hydroxylamine derivatives |
| 03/13/1993 | CA2077948A1 Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents |
| 03/10/1993 | EP0530992A2 Enzymatic deprotection of peptides |
| 03/10/1993 | EP0530903A1 Process for the drying and granulation of aspartame |
| 03/10/1993 | EP0530505A2 Hydantoin derivatives |
| 03/10/1993 | EP0346460B1 Purine derivatives having pharmacological action |
| 03/10/1993 | CN1069736A New isosteric peptides |
| 03/10/1993 | CN1069735A Rapid synthesis and screening of peptide mimetics |
| 03/10/1993 | CN1069730A 2-Piperazinone compounds their production and use |
| 03/09/1993 | US5192746 Cyclic cell adhesion modulation compounds |
| 03/09/1993 | CA1314358C Process for the production of n-formyl-aspartyl- phenylalanine or its methyl ester |
| 03/04/1993 | WO1993004373A1 Calcium receptor active molecules |
| 03/04/1993 | WO1993004079A1 Method for generating and screening useful peptides |
| 03/04/1993 | WO1993004043A1 Anti-hiv (aids) agents |
| 03/04/1993 | CA2116013A1 Method for generating and screening useful peptides |
| 03/04/1993 | CA2115581A1 Anti-hiv (aids) agents |
| 03/03/1993 | EP0530167A1 New isosteric peptides |
| 03/03/1993 | EP0529858A1 2-Piperazinone compounds, their production and use |
| 03/03/1993 | EP0529713A1 Affinity chromatography matrix useful in purifying interleukin-1B converting enzyme |
| 03/03/1993 | EP0529568A1 Novel orally-active elastase inhibitors |
| 03/03/1993 | EP0529504A2 Apparatus for the simultaneous synthesy of different peptides |
| 03/03/1993 | EP0529413A2 Method of separating organic solvents |
| 03/03/1993 | EP0529410A2 Antibiotic GE 2270 factor C2a |
| 03/03/1993 | EP0529031A1 Improved inhibitors of thrombin |
| 03/03/1993 | EP0528854A1 Fluorogenic peptides and their use in the determination of enzymatic activities. |
| 03/03/1993 | EP0528820A1 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase. |
| 03/03/1993 | CA2077198A1 Process for the drying and granulation of aspartame |
| 03/02/1993 | US5191065 Process for the preparation of tripeptides |
| 03/02/1993 | US5190924 Peptide amides and amide dimers useful as muscle relaxants |